Drug-induced cholangiohepatitis accounts for 20-50% of non-viral chronic hepatitis cases. Metformin is the most commonly prescribed oral anti-diabetic drug from the biguanide class used in treatment of overweight and obese type 2 diabetes mellitus patients. Metformin-induced cholangiohepatitis with marked elevations in serum liver transaminases and intrahepatic cholestasis has been infrequently reported. Here, we report a case of acute cholangiohepatitis after initiation of metformin treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028181 | PMC |
| http://dx.doi.org/10.1136/bcr.09.2008.0950 | DOI Listing |
Publication Analysis
Top Keywords
metformin-induced cholangiohepatitis
8
cholangiohepatitis drug-induced
4
drug-induced cholangiohepatitis
4
cholangiohepatitis accounts
4
accounts 20-50%
4
20-50% non-viral
4
non-viral chronic
4
chronic hepatitis
4
hepatitis cases
4
cases metformin
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!